The COVID-19 pandemic may be over, but our immune systems are still feeling the impact. After years of battling constant viral threats, from COVID-19 to seasonal flu and other infections, our body’s defense system is exhausted. Many people continue to experience lingering inflammation, frequent illnesses, and slower recovery times. This extended state of immune stress has compromised us further to chronic illness, including autoimmune diseases and even neurodegenerative diseases such as Parkinson's. So why is our immune system still in trouble? And how do we give it its power back? Understanding immune exhaustion is the beginning of rebuilding our body's natural immunity.
A weakened immune system makes people more susceptible to disease, mental illnesses, and even sleep disorders. Now, new research indicates that immune system depletion may play an important role in the onset of Parkinson's disease, a degenerative neurologic disorder that compromises movement and cognition.
Dysfunctional immune response is a leading cause of long-standing inflammation within the body, that has been found to contribute towards a multitude of conditions, including cardiovascular conditions, diabetes, depression, and neurodegenerative diseases such as Alzheimer's.
As people age, their immune system naturally becomes less effective. This deterioration, referred to as immune exhaustion, may be a key contributor to the onset and progression of Parkinson’s disease. Rebecca Wallings, a Parkinson’s Foundation Launch Award grant recipient and senior postdoctoral fellow at the University of Florida, believes that an accumulation of exhausted immune cells could be driving neurodegeneration in Parkinson’s patients.
Parkinson's disease is most commonly linked with the degeneration and loss of dopaminergic neurons—motor nerve cells that produce dopamine, an essential neurotransmitter for movement. While researchers have long suspected inflammation is involved in this neurodegeneration, the mechanisms are not yet well understood.
Wallings' study is on immune cell exhaustion, a process by which aging immune cells fail to control immune responses effectively. Her research indicates that instead of dampening inflammation in Parkinson's patients, attempts should be made to rejuvenate the immune system to regain its functionality.
One of the major findings of Wallings' work is the function of mitochondrial impairment in immune cell exhaustion. Mitochondria are commonly called the powerhouses of cells, as they are vital for generating energy. As mitochondria age and become inefficient, immune cells fail to function well, potentially accelerating neurodegeneration in Parkinson's disease.
Wallings has found that mutations in the LRRK2 gene, a recognized genetic risk factor for Parkinson's disease, are linked with defective mitochondrial function and immune cell exhaustion. Her current work includes testing various therapeutic approaches to restore mitochondrial function in immune cells with the potential to enhance the immune system and potentially prevent or treat Parkinson's disease.
For decades, the standard practice in treating Parkinson's has been to suppress brain inflammation. Yet Wallings' work indicates that instead of slowing down immune responses, restoring the immune system could be a more successful strategy. By addressing mitochondrial impairment and immune resilience, researchers can potentially reverse or slow down Parkinson's disease.
Wallings is now looking into how to rejuvenate immune cells by fixing mitochondria. She studies immune cells from patients with Parkinson's as well as from healthy subjects and performs experiments on animal models to determine if rejuvenation of the immune system could result in improved disease outcomes.
While there is no cure for Parkinson's disease, some lifestyle adjustments may decrease the chances of developing the illness. Since neurodegenerative diseases are associated with chronic inflammation and immune dysfunction, developing habits that enhance immune function might prove helpful.
Diet: There is evidence to suggest that eating in accordance with the Mediterranean or MIND diets, both high in antioxidants, healthy fats, and anti-inflammatory foods, can encourage brain wellness and reduce Parkinson's risk.
Avoiding Dangerous Substances: Restricting alcohol and nicotine use can maintain a robust immune system and suppress inflammation.
Reducing Stress: Chronic stress weakens immune function, so methods such as meditation, exercise, and sufficient sleep can lead to improved overall well-being.
Credits: Harm and Evidence Research Collaborative and Association for Women In Science
This common pregnancy drug could be linked to cancer. Wes Streeting has been urged to launch a public inquiry into a miscarriage drug called Diethylstilbestrol, which, reports say has "ruined and devastated" the lives of countless women. On Monday, the Health Secretary Streeting met victims of the pregnancy drugs, which has been linked to cancer, early menopause and infertility.
Diethylstilbestrol, commonly known as DES, is a synthetic form of female hormone estrogen, which was prescribed to thousands of pregnant women from 1940 to 1970s.
The drug was used to prevent miscarriage, premature labor and complications of pregnancy. This was also used to suppress breast milk production, as an emergency contraception and to treat symptoms of menopause.
In 1971, Diethylstilbestrol (DES) was linked to a rare cancer of the cervix and vagina known as clear cell adenocarcinoma, prompting US regulators to advise that it should no longer be prescribed to pregnant women. Despite this, the drug continued to be given to expectant mothers across parts of Europe until 1978. DES has also since been associated with other cancers, including breast, pancreatic and cervical cancers, The Telegraph reported.
Campaign group DES Justice UK (DJUK) is now urging Health Secretary Wes Streeting to order a public inquiry and introduce an NHS screening programme to identify people who may have been exposed to the drug before birth.
Victims described DES as “one of the biggest pharmaceutical scandals this country has ever seen,” warning that “the impact of this terrible drug cannot be underestimated as it has ruined and devastated so many lives,” according to The Telegraph.
In November, Streeting acknowledged that the “state got it wrong” and issued an apology to those affected. He also advised anyone who believes they may have been exposed to DES to speak to their GP.
Susie Martin, 55, from Manchester, whose mother was prescribed DES during pregnancy, told The Telegraph she has undergone between 20 and 30 operations as a result of the drug’s effects.
“The impact of this terrible drug cannot be underestimated as it has ruined and devastated so many lives, including my own,” she said. “The physical and emotional pain has been unbearable. I live with a constant fear that I will need more surgery or develop cancer—and I am far from the only one.”
Calling DES a “silent scandal,” Martin said she hopes the government’s engagement will lead to concrete action. “While I welcome Mr Streeting meeting us, it will only matter if he commits to meaningful steps for victims of this shameful chapter in British medical history, including a screening programme and a full statutory public inquiry,” she added.
The Telegraph reported that compensation schemes have been set up for DES victims in the US and Netherlands, however, UK does not have one yet.
"There are harrowing accounts of harm caused by the historic use of Diethylstilbestrol (DES). Some women and their relatives are still suffering from the associated risks of this medicine which have been passed down a generation, and haven’t been supported. The Secretary of State has been looking seriously at this legacy issue and carefully considering what more the government can do to better support women and their families who have been impacted. NHS England has alerted all cancer alliances to this issue so that healthcare professionals are aware of the impacts of DES and the existing NHS screening guidance which sets out the arrangements for those who show signs and symptoms of exposure,” said a Department of Health and Social Care spokesman to The Telegraph.
Credits: Canva/Amazon
The World Health Organization (WHO)'s Montreal meeting focused on wearable technology like smartwatches and activity trackers as a reliable source of health tracking. The meeting discussed that wearables could in fact generate objective real-time data, which helps governments design targeted and evidence-based health interventions.
Physicians in the Montreal meetings discussed that wrist-worn devices are more reliable than traditional self-reported surveys. This is because the self-reported surveys could underestimate the levels of physical inactivity.
“Metrics such as step count, moderate-to-vigorous physical activity and sedentary time directly correlate with cardiovascular disease, diabetes and mental health outcomes. Having population-level data allows for early and preventive strategies,” said Dr Venkat Nani Kumar, consultant in internal medicine.
Doctors in India have welcomed this shift to wearable devices as a better way to generate data and make policies. Dr Kiran Madhala, professor at Gandhi Medical College, Secunderabad, said WHO’s shift reflects rapid advances in artificial intelligence and digital health tools, calling it a progressive step towards improved monitoring of physical activity worldwide.
City-based doctors also underlined the need for inclusive validation of devices. “Wearables must recognise varied movement patterns and step equivalents, especially in ageing populations,” a physician said, while stressing the importance of data privacy and ethical use of health information.
As per a 2022 study published in JMIR MHealth and UHealth, wearables refer to devices that are worn by individuals. In health care field, they assist with individual monitoring and diagnosis. Wearables are “seamlessly embedded portable computers...worn on the body," notes another 2018 study published in Telematics Informatics.
A 2018 study published in the journal Sensors noted that wearable health devices are increasingly helping people to better monitor their health status both at an activity/fitness level for self health tracking and at a medical level providing more data to clinicians with a potential for earlier diagnostic and guidance of treatment.
This is a blood pressure monitor that consists of a cuff that is placed in upper arm with a digital display that provides real time reading of systolic and diastolic blood pressure.
This device estimates your glucose levels in every few minutes. It can be worn in upper arm, with a phone sensor connected to measure readings. It also includes real time glucose alarms to make informed decisions.
ECG patches are interconnected with smartphones, where one can see their readings. They not only measure electrocardiograms, but also detect any abnormalities.
Smartwatches or fitbits that could be worn on your wrist. They help track real time data of your health, steps, heart rate, calorie consumptions, and even sleep patterns. It can also help keep track of oxygen levels.
These activewears come with microscopic sensors to safeguard wearer's body or assist them in reaching their fitness objective.
Credits: Canva
Epilepsy affects more than 15 million people in India, yet it remains one of the most misunderstood neurological conditions. Despite being a treatable brain disorder, fear, stigma and long-standing myths continue to delay diagnosis and care, especially in smaller towns and rural areas. Doctors say this lack of awareness often causes more harm than the condition itself.
According to the World Health Organization (WHO), nearly 50 million people worldwide live with epilepsy, making it one of the most common neurological disorders. The WHO also estimates that up to 70 per cent of people with epilepsy can live seizure-free if properly diagnosed and treated. Yet, in low- and middle-income countries, almost three-fourths of patients do not receive the treatment they need.
Dr Madhukar Bhardwaj, Director and Head of Neurology at Aakash Healthcare, explains that epilepsy occurs due to a sudden disturbance in the brain’s electrical activity. “A seizure happens when the brain’s electrical signals stop working normally for a short time,” he says.
This can cause a wide range of symptoms, from jerking movements and falling unconscious to staring spells or brief confusion. “Some seizures last just a few seconds and may go unnoticed, while others can be severe,” Dr Bhardwaj adds.
Despite medical clarity, myths around epilepsy remain deeply rooted. Dr Bhardwaj points out that many people still believe epilepsy is caused by ghosts, black magic, or divine punishment. “Others think it spreads by touch or that people with epilepsy cannot study, work or get married,” he says.
One of the most dangerous misconceptions is putting an object into a person’s mouth during a seizure. “This is completely false and can seriously injure the patient,” Dr Bhardwaj warns. Doctors stress that epilepsy should be treated like any other chronic condition, such as diabetes or high blood pressure, not as a social taboo.
Dr Neha Kapoor, Associate Director and Head of Neurology at Asian Hospital, says epilepsy does not have one single cause. “In many cases, we are unable to find an exact reason,” she explains. However, known causes include genetic factors, head injuries from accidents, brain infections like meningitis, strokes, and other forms of brain damage.
In children, epilepsy may result from lack of oxygen at birth or abnormal brain development before birth. Dr Kapoor also clarifies a common misunderstanding: “Stress, lack of sleep, and alcohol can trigger seizures, but they are not the root cause of epilepsy.”
Not all seizures look dramatic, which leads to frequent delays in diagnosis. “Not all seizures involve shaking,” says Dr Praveen Gupta, Chairman at Marengo Asia International Institute of Neuro and Spine (MAIINS). “Some look like daydreaming or sudden confusion, which is why epilepsy is often missed.”
Dr Gupta notes that many patients reach specialists very late due to fear and misinformation. “With timely treatment, most people with epilepsy can live completely normal lives,” he says.
Nearly 70 per cent of epilepsy patients can control seizures with regular medication, according to doctors. For those who do not respond to medicines, known as drug-resistant epilepsy, advanced treatment options are now available in India.
“Epilepsy surgery is being used successfully,” Dr Gupta explains. “We carefully identify the part of the brain causing seizures and treat it safely. This can greatly reduce or even stop seizures.” He adds that modern surgical and neuro-robotic techniques are changing outcomes and offering renewed hope.
Epilepsy can also affect aspects of life that are rarely discussed, including sexual health. Dr Vineet Malhotra, Principal Consultant at SCM Healthcare, says seizures, stress and some anti-seizure medications may impact energy levels, hormones and sexual desire in men.
“However, these issues are manageable,” Dr Malhotra says. “With counselling, lifestyle changes and medication adjustments, patients can lead healthy, active and fulfilling lives.”
Doctors agree that awareness, early diagnosis and breaking myths are key to ensuring epilepsy is treated as what it truly is, a manageable medical condition, not a social label.
© 2024 Bennett, Coleman & Company Limited